A common injury in the hip joint is a tear of the muscles, cartilage, or other soft tissues
That is why every efficacy statement here is hedged with studied for, in research, or preclinical. It is not lawyerly throat-clearing
Meanwhile, it is important to note that there is a concern that prolonged use of angiogenesis-promoting agents, such as BPC-157, TB-500, and GHK-Cu, might have the potential for complications, which are discussed in peptide safety articles also published on Peptides.org
Retatrutide is not a licensed medicine in the United Kingdom
The potential is enormous, but only if the work is done right
Lei J, Sun LC, Huang S, Zhu C, Li P, He J, Mackey V, Coy DH, He QY (2019) The antimicrobial peptides and their potential clinical applications